PD-008 Adding ramucirumab to second-line irinotecan, 5-fluorouracil and folinic acid (FOLFIRI) treatment for metastatic colorectal carcinoma (mCRC): resource utilization data from RAISE, a global, randomized, double-blind, multicenter phase 3 study

Saved in:

Bibliographic Details
Published in:	Ann Oncol
Main Authors:	Kisro, J., Cohn, A., Yoshino, T., Van Cutsem, E., Hegewisch-Becker, S., Kullmann, F., Brück, P., Liepa, A., Yang, L., Nasroulah, F., Tabernero, J.
Format:	Artigo
Language:	Inglês
Published:	Oxford University Press 2016
Subjects:	Abstracts
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4984156/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdw200.08
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items